Home

CHARLES R SCHALLER

CIK 903696 · last filed 2010-09-13

CHARLES R SCHALLER is a corporate insider who has filed 14 SEC Form 4 insider transactions across 2 companies since 2007. Across all open-market trades the lifetime net is −$799.5K, making them a net seller over the disclosed history. 18 SEC filings were submitted jointly with MEDAREX INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

14

Lifetime Open-Market Net

-$799.5K

Filer Profile

Related Filers
MEDAREX INC — 18 joint filings, latest 2009-09-03
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
MEDX Director 0 $34.96 $0 -$799.5K 7 2009-08-31
Celldex Therapeutics, Inc. (AVAN) Delisted Director — $10.04 — $0 1 2008-09-29

Recent Filings

14 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2010-09-13 — Buy (P) +5,000 $17.2K
2009-12-24 — Grant (A) +2,000 $0
2009-12-03 — Buy (P) +7,000 $32.8K
2009-11-12 — Buy (P) +10,000 $51.6K
2009-09-03 — Disp (D) — $0
2009-08-31 MEDX U −33,274 -$532.4K EDGAR
2009-03-09 MEDX Grant (A) — $0 EDGAR
2008-11-14 — Buy (P) +3,000 $18.3K
2008-09-29 Celldex Therapeutics, Inc. (AVAN) Delisted Grant (A) — $0 EDGAR
2008-05-19 MEDX Grant (A) — $0 EDGAR
Showing 1–10 of 14
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.